InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'
InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'
inmed pharmaceuticals股價上漲,因該公司宣佈獲得了美國專利US 12083229 B2 16/611837,用於「眼部藥物給藥配方」。
InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'
inmed pharmaceuticals股價上漲,因該公司宣佈獲得了美國專利US 12083229 B2 16/611837,用於「眼部藥物給藥配方」。